What are the chances for running and developing companies in life science in Sweden today? Which financing options are suitable for different companies? When should you start planning for different exit strategies? How can a small company plan when it comes to partnerships and possible acquisitions?
On March 31, Stockholm Science City held a seminar with the following speakers:
- Magnus Persson, Founding Partner at Eir Ventures
- Mårten Winge, CEO at Strike Pharma
- Per Lek, Business Developer at Stockholm Science City